Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|7|814-822

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.7, 2012-09, pp. : 814-822

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 459-467

Bentham Science Publishers

Access to resources Recommend Favorite

Transgenic Mouse Models with Tau Pathology to Test Therapeutic Agents for Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 1, 2002-02 ,pp. : 51-58

Bentham Science Publishers

Access to resources Recommend Favorite

Antiangiogenic Therapeutic Approaches in Multiple Myeloma

By  

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-09 ,pp. : 768-775

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case‐based approach

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 258-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

The kinase NIK as a therapeutic target in multiple myeloma

By Gardam Sandra   Beyaert Rudi  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 207-218

Informa Healthcare

Access to resources Recommend Favorite